News
Rocket Pharma receives US FDA regenerative medicine advanced therapy designation for RP-A601 gene therapy: Cranbury, New Jersey Saturday, July 19, 2025, 15:00 Hrs [IST] Rocket Pha ...
THE Pocket Rocket Foundation is now accepting applications for its 2025–2026 scholarship programme, reaffirming its ...
Rocket Lab USA, Inc. (NASDAQ:RKLB) is one of the best space stocks to buy according to hedge funds. Fresh off a Citi analyst ...
Rocket Lab’s share price has broken through the US$50 mark for the first time after experiencing a 7.6% boost overnight, ...
Welcome to Edition 8.03 of the Rocket Report! We are at an interesting stage in Europe, with its efforts to commercialize ...
Rocket has expanded its SEO services to include generative AI SEO, helping brands appear in AI-powered platforms including ...
HUNTSVILLE, Ala. ( WAFF) - Many came together in the Rocket City on Thursday to celebrate Huntsville’s ticket into the Space Race. The Marshall Space Flight Center was born sixty-five years ago this ...
Rocket Lab is a leading launch services provider. Bank of America has upwardly revised its price target due, in part, to the ...
Rocket Mortgage Classic returns to Detroit Golf Club this week, offering more than just a summer stop on the PGA Tour calendar. In just seven years, the tournament has developed into an invaluable ...
3d
InvestorsHub on MSNRocket Pharmaceuticals Shares Jump After FDA Grants Accelerated Review Status to Gene TherapyRocket Pharmaceuticals Inc. (NASDAQ:RCKT) surged 15% after receiving a key regulatory boost from the U.S. Food and Drug ...
Rocket Pharmaceuticals (NASDAQ:RCKT) said that the U.S. FDA has given regenerative medicine advanced therapy (RMAT) status to their gene therapy, RP-A601, for treating a heart condition known as ...
Investing.com -- Rocket Pharmaceuticals Inc (NASDAQ: RCKT) stock surged 15% after the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results